Media Centre
Releases
January 27, 2016: NGDI to host Peter J. Hotez: Centennial Session in Global Health
October 5, 2015: Four gut bacteria decrease asthma risk in infants
August 4, 2015: New weapon in the fight against malnutrition
February 13, 2015: NGDI Member Urs Hafeli to Lead International Professorship
November 20, 2014: Canadian Researchers Come Together to Combat the Ebola Outbreak
October 23, 2014: Rapid test to diagnose severe sepsis
September 18, 2014: NGDI receives core funding from UBC Administration and the Vancouver Coastal Health Research Institute
September 2, 2014: iCo Therapeutics Announces Positive Oral Amphotericin B Study Results
July 21, 2014: Promising discovery in the fight against antibiotic-resistant bacteria
May 1, 2014: Clinical Infectious Disease and mHealth Researcher to Lead Neglected Disease Work at UBC
March 9, 2014: NGDI’s Mark Ansermino and Peter von Dadelszen’s Innovative Phone Oximeter (TM) Receives $2M Funding Boost
March 6, 2014: NGDI Member Dr. Richard Lester Receives UBC’s first $2 Million Grand Challenges Canada Scale-up Grant
February 17, 2014: South African healthcare workers face greater risk for TB, HIV
February 11, 2014: Dr. Kish Wasan appointed new Dean of School of Pharmacy and Nutrition, University of Saskatchewan
December 20, 2013: UBC-VCH scientists use drug to repair a rare birth defect
December 12, 2013: iCo Therapeutics Announces Program and Intellectual Property Advancements for Oral Amphotericin B
December 2, 2013: UBC joins WIPO Re:Search to tackle Neglected Diseases
May 15, 2013: Canadian Experts in Global Health to create new Canadian Global Health Research Training Program
April 29, 2013: CORE Partners with NGDI-UBC in Neglected Global Disease Research
November 22, 2012: ‘Repurposed’ anti-parasite drug shows promise as new TB treatment: UBC research
November 8, 2012: NGDI Member Peter von Dadelszen receives $17M for Pre-eclampsia Research
October 16, 2012: iCo Therapeutics’ Oral Amphotericin B Delivery System to be Presented
at AAPS with Updated Patent Position
September 10, 2012: Funding for neglected global diseases research at UBC exceeds $20M
June 20, 2012: UBC Research receives $2.9 million to improve nutrition of rural Cambodian women and children
June 5, 2012: UBC drug formulation receives $1.1 million for clinical development as HIV treatment
February 28, 2012: UBC researcher invents lab-on-a-chip device to study malaria
February 16, 2012: Fight Against Neglected Global Diseases Moves Another Step Forward Through a Partnership Between CDRD and NGDI-UBC
December 1, 2011: UBC, CFRI and BC Children's researchers to lead $2.8-million project to reduce deadly infection in Bangladeshi mothers, children
October 24, 2011: A novel oral treatment for Leishmaniasis has potential to save thousands of lives - AAPS Annual General Meeting October, 2011.
September 28, 2011: start an evolution: UBC launches Canada's largest fundraising and alumni engagement campaign
August 31, 2011: Three research programs win $6M in CIHR grants to promote global health equity
February 15, 2011: CDRD Partners with NGDI UBC to Develop New Interventions for Neglected Global Diseases
December 7, 2010: UBC-developed formulation of leishmaniasis drug shown to be stable and effective in tropical temperature
December 3, 2010: UBC/CFRI project receives $7M to reduce maternal, fetal, and newborn deaths
November 15, 2010: Dr. Tobias Kollmann heads structured collaboration with Advaxis, Inc.
November 9, 2010: Text messaging improves health of Kenyans with HIV: UBC researcher
September 29, 2010: iCo Therapeutics Oral Amphotericin Program Receives FDA Orphan Drug Status
May 18, 2010: UBC researchers call for “social offset” to tackle neglected tropical diseases
Brand Logo
A full .PNG version of the NGDI-UBC logo is available for download here.